Financial Analysis: Olema Pharmaceuticals Inc (OLMA)’s Ratios Unveil Key Insights

Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, Olema Pharmaceuticals Inc’s stock clocked out at $6.15, down -2.69% from its previous closing price of $6.32. In other words, the price has decreased by -$2.69 from its previous closing price. On the day, 0.82 million shares were traded. OLMA stock price reached its highest trading level at $6.38 during the session, while it also had its lowest trading level at $6.03.

Ratios:

To gain a deeper understanding of OLMA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.10 and its Current Ratio is at 7.10. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on April 02, 2024, initiated with a Buy rating and assigned the stock a target price of $24.

On January 30, 2024, Citigroup started tracking the stock assigning a Buy rating and target price of $20.

On July 21, 2023, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $21.Oppenheimer initiated its Outperform rating on July 21, 2023, with a $21 target price.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 17 ’24 when Graham G. Walmsley sold 700,761 shares for $6.75 per share. The transaction valued at 4,730,137 led to the insider holds 0 shares of the business.

Logos Opportunities Fund I LP bought 700,761 shares of OLMA for $4,730,137 on Dec 13 ’24. On Dec 10 ’24, another insider, Harmon Cyrus, who serves as the Director of the company, sold 8,256 shares for $9.37 each. As a result, the insider received 77,359 and left with 772,277 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OLMA now has a Market Capitalization of 453911232 and an Enterprise Value of 137965232.

Stock Price History:

Over the past 52 weeks, OLMA has reached a high of $16.77, while it has fallen to a 52-week low of $5.56. The 50-Day Moving Average of the stock is -36.95%, while the 200-Day Moving Average is calculated to be -45.42%.

Shares Statistics:

It appears that OLMA traded 662.67K shares on average per day over the past three months and 1217790 shares per day over the past ten days. A total of 57.29M shares are outstanding, with a floating share count of 42.88M. Insiders hold about 25.17% of the company’s shares, while institutions hold 84.98% stake in the company. Shares short for OLMA as of 1734048000 were 9965564 with a Short Ratio of 15.04, compared to 1731628800 on 8562407. Therefore, it implies a Short% of Shares Outstanding of 9965564 and a Short% of Float of 20.13.

Most Popular